Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Psychosocial Oncology|December 14, 2019
A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support personsWilliam Stevenson, Jamie Bryant, Rochelle Watson, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2022
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patientsPhilip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, et al.
Pathology|December 4, 2020
Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiativeGreg Corboy, Jad Othman, Linda Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II StudyAndrew H Wei, Stephen A Strickland, Jing-Zhou Hou, et al.
Oncotarget|June 23, 2016
Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitorsAmanda M Smith, Matthew D Dun, Erwin M Lee, et al.
Blood Research|January 12, 2023
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, et al.
Blood Advances|February 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapyAndrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, et al.
Blood Cancer Journal|March 27, 2024
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Ing Soo Tiong, Meaghan Wall, Ashish Bajel, et al.
Blood Cancer Journal|June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE databaseJan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.
Pageof 2